Clinical trial
REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
NCT03251131 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 8, 2017
- Completion date
- April 30, 2020
- Enrollment
- 100 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.